Your browser doesn't support javascript.
loading
Metabolic constraints on the evolution of antibiotic resistance.
Zampieri, Mattia; Enke, Tim; Chubukov, Victor; Ricci, Vito; Piddock, Laura; Sauer, Uwe.
Afiliação
  • Zampieri M; Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland zampieri@imsb.biol.ethz.ch sauer@imsb.biol.ethz.ch.
  • Enke T; Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland.
  • Chubukov V; Institute of Biogeochemistry and Pollutant Dynamics (IBP), ETH Zürich, Zürich, Switzerland.
  • Ricci V; Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland.
  • Piddock L; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Sauer U; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Mol Syst Biol ; 13(3): 917, 2017 03 06.
Article em En | MEDLINE | ID: mdl-28265005
ABSTRACT
Despite our continuous improvement in understanding antibiotic resistance, the interplay between natural selection of resistance mutations and the environment remains unclear. To investigate the role of bacterial metabolism in constraining the evolution of antibiotic resistance, we evolved Escherichia coli growing on glycolytic or gluconeogenic carbon sources to the selective pressure of three different antibiotics. Profiling more than 500 intracellular and extracellular putative metabolites in 190 evolved populations revealed that carbon and energy metabolism strongly constrained the evolutionary trajectories, both in terms of speed and mode of resistance acquisition. To interpret and explore the space of metabolome changes, we developed a novel constraint-based modeling approach using the concept of shadow prices. This analysis, together with genome resequencing of resistant populations, identified condition-dependent compensatory mechanisms of antibiotic resistance, such as the shift from respiratory to fermentative metabolism of glucose upon overexpression of efflux pumps. Moreover, metabolome-based predictions revealed emerging weaknesses in resistant strains, such as the hypersensitivity to fosfomycin of ampicillin-resistant strains. Overall, resolving metabolic adaptation throughout antibiotic-driven evolutionary trajectories opens new perspectives in the fight against emerging antibiotic resistance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência Microbiana a Medicamentos / Escherichia coli / Metabolômica / Ampicilina Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência Microbiana a Medicamentos / Escherichia coli / Metabolômica / Ampicilina Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article